Cost/Effectiveness Analysis of the Respiratory Poligraphy at Home
NCT ID: NCT00614952
Last Updated: 2016-04-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
320 participants
INTERVENTIONAL
2006-01-31
2016-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cost-effectiveness of Home Respiratory Polygraphy
NCT01752556
Diagnosis of Patients With Low or Intermediate Suspicion of SAHS or With Comorbidity: Standard Laboratory Polysomnography Compared With Three Nights of Home Respiratory Polygraphy.
NCT01820156
Home Nasal Pressure for Sleep Apnea Management in Primary Case
NCT02141165
Validity of a Home Respiratory Polygraphy for the Diagnosis of Obstructive Sleep Apnea
NCT03415633
Home Diagnosis and Treatment of Obstructive Sleep Apnea
NCT00139022
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PR
PR (respiratory polygraphy)
respiratory polygraphy: level III of AASM
PSG
PSG (polysomnography)
POLYSOMNOGRAPHY
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PSG (polysomnography)
POLYSOMNOGRAPHY
PR (respiratory polygraphy)
respiratory polygraphy: level III of AASM
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Without clinical suspicion referred to any other sleep pathology susceptible of presenting daytime sleepiness.
3. Living 20 Km or more far from the hospital participating in the study.
Exclusion Criteria
2. Patients who do not get pass the proof of placing the PR (see below).
3. Patients who present restrictive chronic disease previously diagnosed (neoplasy, any origin chronic pain, renal failure, severe chronic obstructive pulmonary disease and any other limited chronic disease)
4. Structural cardiopaty or coronary documented non controlled by means of medical treatment .
5. Toxicomanies. Alcoholism (more than 80 gr/day in men and 60 gr/day in women.
6. Informed consent not obtained.
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sociedad Española de Neumología y Cirugía Torácica
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Juan F. Masa
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Juan F. Masa, MD
Role: PRINCIPAL_INVESTIGATOR
Hospital San Pedro de Alcántara. Cáceres. Spain
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital San Pedro de Alcántara. Servicio Extremeño de Salud
Cáceres, Caceres, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI 050444
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.